Cas:53808-88-1 lonazolac manufacturer & supplier

We serve Chemical Name:lonazolac CAS:53808-88-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

lonazolac

Chemical Name:lonazolac
CAS.NO:53808-88-1
Synonyms:2-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]acetic acid;Lonazolacum;Irritren;Lonazolaco;Lonazolac
Molecular Formula:C17H13ClN2O2
Molecular Weight:312.75000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:525.1ºC at 760mmHg
Density:1.3g/cm3
Index of Refraction:
PSA:55.12000
Exact Mass:312.06700
LogP:3.81980

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Lonazolac physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Irritren Use and application,2-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]acetic acid technical grade,usp/ep/jp grade.


Related News: But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. lonazolac manufacturer They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients. lonazolac supplier But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. lonazolac vendor But several border points remain open, and many medical workers fear that Hong Kong��s well-regarded health care system will be overwhelmed. lonazolac factory While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added.